
    
      The Neo Randomized Heart Failure Study is a prospective, randomized, study describing the
      safety and efficacy of the BAROSTIM NEO System in the heart failure participants with a left
      ventricular ejection fraction â‰¤ 35%.

      During long-term follow-up, all participants are required to have at least one annual visit.

      Parameters assessed during long-term follow-up visits:

        -  Physical Assessment

        -  Subject Medications

        -  Serious adverse events
    
  